Dhru Purohit

That's great.

I love the visual because it really drives the idea home that it's that tiny little tweak of these, I don't know if the right term is fractional dosing or whatever it might be, that makes all the difference

in terms of the letdown of getting people off of this process and allowing their body to achieve that homeostasis in a much more peaceful and stabilized way.

And that is the difference between somebody who can get off of this generally through a very smooth process versus somebody who feels like their life is turning upside down completely from getting off these medications.

So this world is pretty controversial in your community, right?

There's a lot of different views that people have, people not up to date on the latest information.

And you have leaned into that controversy and addressed it head on.

But give a little bit of a snapshot because, you know, folks that are listening here, everything you're saying, they're nodding their head.

They're, oh, my gosh, this is amazing.

This makes so much sense.

If this makes so much sense and it's so obvious, like, why isn't everybody doing this?

And part of that is that layer of some of that controversy.

So explain the landscape.

Who are the detractors, the people that feel that this isn't needed, it isn't useful, there's not enough research on it?

Who are the groups and what do they believe?

Yeah, and therefore by also acknowledging that, that some people might need to come off, that most people would benefit from getting off slowly and that their withdrawal symptoms are an issue,

I guess that opening up that can of worms also just opens up the whole can of worms of are SSRIs the first-line therapy approach that should be prescribed in many of these situations?

Or should we take a little bit more of an approach to look at many other proven things that are there, or at least have the patient have more informed consent?

I guess if you're opening the can of worms on withdrawal symptoms, that also opens

I can imagine, is very scary for these drug companies and the spokespeople that are part of it that, okay, what's next after that?